Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
      Google Scholar   
Citation:
J Clin Oncol vol 21 (4) 607-14
Year:
2003
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Lymphoma
Sec. Committees:
   
Pharmas:
 
Grants:
CA 31946  
Corr. Author:
 
Authors:
                 
Networks:
 
Study
Alliance-8952
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
Keywords:
Adult, Antineoplastic Combined Chemotherapy Protocols, Bleomycin, Confidence Intervals, Dacarbazine, Disease-Free Survival, Doxorubicin, Female, Hodgkin Disease, Humans, Male, Mechlorethamine, Prednisone, Procarbazine, Survival Rate, Vinblastine, Vincristine